跳至主要内容
临床试验/CTRI/2019/09/021087
CTRI/2019/09/021087尚未招募2 期

A clinical evaluation of Anti obesity(sthoulyahara) action of Triphala Madhupaka

Dr Madan Kumar S D1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年11月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
All the patients who fit in inclusion criteria will be given treatment with Triphala Madhupaka 6gm twice daily before food

研究概览

简要总结

Ayurveda recommended intake of food articles that which maintain the health and prevent un manifested diseases. An ancient balanced diet consists of food articles which are listed in Nithyasevaniyaahara. Madhu is one among the nithyasevaniyaahara. It has medohara and lakshanas effect when it is one year old. Obesityis a medical condition in which excess body fat accumulates to an extent that it may have a negative effect on health. Obesity increases the likely hood of various diseases, particularly heart disease, type 2 diabetes, obstructive sleep apnoea, certain types of cancer, and osteoarthritis. Obesity is most commonly caused by a combination of excessive food intake, lack of physical activity, and genetic susceptibility.Worldwide obesity has nearly tripled since 1975.In 2016, more than 1.9 billion adults, 18 years and older, were overweight Of these over 650 million were obese.39% of adults aged 18 years and over were overweight in 2016, and 13% were obese. Most of the world’s  population in countries where overweight and obesity kills more people than underweight. Ayurveda emphasizes the use of Purana Madhu as a nutritional therapy in Sthoulya. Triphala is another drug used in combination for the same. Triphala Madhupaka is experimentally analysed for its, in-vitro anti-obese action and found to be safe for oral consumption. But it is not clinically proven hence, in this study Triphala Madhupaka will be used to assess its anti-obese action..

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Ready to give informed return consent.

排除标准

  • Obesity due to secondary causes PCOD Hypothyroidism History of steroidal or hormonal therapy, oral contraception Patients suffering from chronic metabolic disorders Subjects with mental illness.

结局指标

主要结局

All the patients who fit in inclusion criteria will be given treatment with Triphala Madhupaka 6gm twice daily before food

时间窗: will be assessing on baseline treatment, 15th day and on 30th day

次要结局

  • Quality of life(will be assessing on baseline treatment, 15th day and on 30th day)

研究者

发起方
Dr Madan Kumar S D
申办方类型
Other []

研究点 (1)

Loading locations...

相似试验

Anti obese potential of Triphala Madhupaka | 临床试验